Structure and inhibition mechanism of some synthetic compounds and phenolic derivatives as tyrosinase inhibitors: review and new insight
- PMID: 35510568
- DOI: 10.1080/07391102.2022.2069157
Structure and inhibition mechanism of some synthetic compounds and phenolic derivatives as tyrosinase inhibitors: review and new insight
Abstract
Safety concerns are the primary consideration to identify and detection of enzyme inhibitors. In this regard, safe and potent tyrosinase inhibitors play important role in enhancing nutritional quality, health promotion and also prevent further damages. The present review focuses on the recent and efficient tyrosinase inhibitors discovered from both synthetic sources and synthesized phenolic compounds, including flavonoid, carvacrol, thymol, cinnamic acid and resorcinol derivatives. The inhibitory activity of these compounds was analyzed according to chemical structure, IC50, Ki and their binding energy. Further, inhibition mechanism and the biological effects of some these inhibitors with potential application in food, agricultural, cosmetic and pharmaceutical industries were briefly discussed. Molecular docking procedure was performed on some derivatives and demonstrated favorable binding affinity with amino acid residues of mushroom tyrosinase (PDB ID: 2Y9X). The information offered showed that the substitution pattern of hydroxyl groups at the phenyl ring is an important factor of tyrosinase inhibitory activity. The results confirmed that understanding structural modification of inhibitors is a key role in finding novel and efficacious tyrosinase inhibitors.Communicated by Ramaswamy H. Sarma.
Keywords: Tyrosinase; drug design; molecular docking; structure; synthetic inhibitors.
Similar articles
-
Carvacrol derivatives as mushroom tyrosinase inhibitors; synthesis, kinetics mechanism and molecular docking studies.PLoS One. 2017 May 23;12(5):e0178069. doi: 10.1371/journal.pone.0178069. eCollection 2017. PLoS One. 2017. PMID: 28542395 Free PMC article.
-
Synthesis, computational studies, tyrosinase inhibitory kinetics and antimelanogenic activity of hydroxy substituted 2-[(4-acetylphenyl)amino]-2-oxoethyl derivatives.J Enzyme Inhib Med Chem. 2019 Dec;34(1):1-11. doi: 10.1080/14756366.2019.1654468. J Enzyme Inhib Med Chem. 2019. PMID: 31456445 Free PMC article.
-
Synthesis, computational studies and enzyme inhibitory kinetics of substituted methyl[2-(4-dimethylamino-benzylidene)-hydrazono)-4-oxo-thiazolidin-5-ylidene]acetates as mushroom tyrosinase inhibitors.Bioorg Med Chem. 2017 Nov 1;25(21):5929-5938. doi: 10.1016/j.bmc.2017.09.009. Epub 2017 Sep 18. Bioorg Med Chem. 2017. PMID: 28988751
-
Design and discovery of mushroom tyrosinase inhibitors and their therapeutic applications.Expert Opin Drug Discov. 2014 May;9(5):533-54. doi: 10.1517/17460441.2014.907789. Epub 2014 Apr 7. Expert Opin Drug Discov. 2014. PMID: 24708040 Review.
-
A systematic review of synthetic tyrosinase inhibitors and their structure-activity relationship.Crit Rev Food Sci Nutr. 2022;62(15):4053-4094. doi: 10.1080/10408398.2021.1871724. Epub 2021 Jan 18. Crit Rev Food Sci Nutr. 2022. PMID: 33459057
Cited by
-
Naturally-Occurring Tyrosinase Inhibitors Classified by Enzyme Kinetics and Copper Chelation.Int J Mol Sci. 2023 May 5;24(9):8226. doi: 10.3390/ijms24098226. Int J Mol Sci. 2023. PMID: 37175965 Free PMC article. Review.
-
Development of new dehydrocostuslactone derivatives for treatment of atopic dermatitis via inhibition of the NF-κB signaling pathway.RSC Med Chem. 2024 Jun 27;15(8):2773-2784. doi: 10.1039/d4md00301b. eCollection 2024 Aug 14. RSC Med Chem. 2024. PMID: 39149113 Free PMC article.
-
Characterization of Phenolic Profile and Biological Properties of Astragalus membranaceus Fisch. ex Bunge Commercial Samples.Antioxidants (Basel). 2024 Aug 16;13(8):993. doi: 10.3390/antiox13080993. Antioxidants (Basel). 2024. PMID: 39199238 Free PMC article.
-
Evaluation of the interactions of hydrazide derivatives with acetic acid and molecular modeling analysis of N-acetylated hydrazides.RSC Adv. 2025 Apr 28;15(17):13618-13627. doi: 10.1039/d5ra01286d. eCollection 2025 Apr 22. RSC Adv. 2025. PMID: 40296993 Free PMC article.
-
Endogenous tyrosinase-catalyzed therapeutics.Nat Commun. 2025 Jul 12;16(1):6463. doi: 10.1038/s41467-025-61799-7. Nat Commun. 2025. PMID: 40651969 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources